American Association for Cancer Research (AACR) 2026

From April 17 to 22, 2026, the AACR Annual Meeting will take place at the San Diego Convention Center in California. As one of the most influential gatherings in global cancer research, the event brings together leading researchers, clinicians, and industry professionals from pharma and biotech to share the latest advances and future directions in cancer diagnosis and treatment.

About AntibodySystem

AntibodySystem, a French-based biotech brand established in 2019, was founded by a team of experts with over 30 years of experience in protein and antibody development. The company specializes in recombinant proteins, antibodies, and RUO ELISA kits, with a current portfolio of more than 35,000 antibodies, 15,000 proteins, and 2,000 ELISA kits.

Product Portfolio & Applications

Its product portfolio supports both academic research and industrial applications — from basic experiments to translational studies. Key applications include:

• WB, IHC, IF, ELISA, and neutralization assays
• Emerging fields such as virology research, vaccine development, drug discovery, and cell and gene therapy (CGT)

The brand offers a comprehensive portfolio designed to streamline research workflows, featuring essential reagents such as loading controls, secondary antibodies, and recombinant rabbit monoclonal antibodies, alongside specialized lines including in vivo functional antibodies, phospho-specific antibodies, PEG antibodies, and DNA/RNA antibodies. These products are widely used in cutting-edge areas like oncology and immunology, providing the global research and drug development community with high-quality tools.

Meet Us at AACR 2026

At AACR 2026, AntibodySystem invites you to visit booth #4928. We look forward to connecting with cancer researchers, clinicians, and pharmaceutical partners from around the world to explore more precise and efficient solutions together.